What is GEMCOVAC-OM?
GEMCOVAC-OM is India’s first indigenous mRNA vaccine for the Omicron variant of the novel coronavirus.
It was approved under emergency use guidelines by the Drug Controller General of India (DCGI).
It was developed by Gennova Biopharmaceuticals Ltd. and supported under the Mission COVID Suraksha, implemented by Biotechnology Industry Research Assistance Council (BIRAC).
It is a thermo-stable vaccine, which does not require ultra-cold chain infrastructure used for other approved mRNA-based vaccines, making it easy for deployment pan India.
GEMCOVAC-OM was stable in a 2-8 degrees Celsius range and hence could be stored in ordinary refrigerators.
It could be administered into the skin via a “needle-free” PharmaJet system.
COMMENTS